Thursday, August 20, 2026

Virtual

Overview

The management of non-Hodgkin lymphoma (NHL) is complex, and oncology pharmacists play a critical role in mastering the complex integration and toxicity of novel agents. Join leading experts in hematologic cancers for PTCE's 2026 Lymphoma Day of Education to review the pathophysiology of NHL subtypes, including aggressive diffuse large B-cell lymphoma and relapsing follicular lymphoma, and pharmacology of novel agents in both frontline and relapsed settings. Register early for these expert-led sessions that will examine clinical and operational strategies for the integration of CAR T-cell therapy and bispecific antibodies in NHL treatment.

The full schedule with agenda details is coming soon.

Moderator

James Davis

PharmD, BCOP

Activity Disclaimer

Pharmacy Times Continuing Education™ (PTCE) strives to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events hosted by PTCE. PTCE reserves the right to cancel an event without notice. PTCE will not be responsible for any expenditure incurred due to the cancellation.

Educational Disclaimer

Continuing professional education (CPE) activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.